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Introduction: The selective medication for pain control in many clinical situations is morphine but its complica-
tions prevent its widespread use. Ketamine has been introduced as an alternative for morphine in some studies. 
However, the efficacy of its solitary use has not yet been evaluated. Therefore, the present study was undertaken 
to evaluate the effect of ketamine alone in relieving pain in trauma patients referring to an emergency unit. 
Methods: In this double-blind clinical trial, patients with long bone fractures were randomly divided into two 
groups of treatment with intravenous (IV) morphine at a dose of 0.1 mg/kg and treatment with IV ketamine at a 
dose of 0.5 mg/kg. Pain severity of the patients was recorded before and 10 minutes after injection based on nu-
meric rating scale. The means in the two groups were compared using independent t-test. Then the Kaplan-Meier 
curve and log rank analysis were used to evaluate the success of treatment. Results: 126 patients were included 
in this study. The mean ages of the patients in the morphine and ketamine groups were 33.6±14.3 and 35.1±13.5 
years, respectively (P=0.54). After therapeutic intervention, the pain severity significantly decreased in ketamine 
(2.7±1.8; P<0.0001) and morphine (2.4±1.5; P<0.0001) groups, with a similar effect of both medications on alle-
viating pain (P=0.28). The success rate of the treatment at 10-minute interval in groups receiving ketamine and 
morphine were 59 (93.65%) and 61 (96.8%) patients, respectively (P=0.62). Conclusion: The results of the pre-
sent study showed that administration of ketamine at a low dose (0.5 mg/kg) results in a significant decrease in 
the severity of acute pain in patients with fractures of long bones. This palliative effect is very similar to that of 
morphine. 
Key words: Bone fracture; pain management; analgesia; ketamine; morphine  
Cite this article as: Majidinejad S, Esmailian M, Emadi M. Comparison of intravenous ketamine with morphine in pain relief of 
long bones fractures: a double-blind randomized clinical trial. Emergency. 2014;2(2):77-80. 
 
Introduction:1 
ractures have a high incidence rate in traffic acci-
dents and are one of the three most important 
complications during accidents (1). Each year 
millions of people all over the world suffer from bone 
fractures, the complications of which threaten the pa-
tients’ health for several years (2, 3). One of the most 
important measures in the management of such pa-
tients in the emergency unit is fixation and pain control. 
Opioids are one of the main and most effective medica-
tions to relieve pain (4, 5) by suppression of pain center 
in the CNS through stimulation of µ and δ receptors. 
However, complications such as dependence, tolerance, 
suppression of respiratory center and activation of 
vomiting center are some of their problems (6). Other 
medications are NSAIDs, which prevent synthesis of 
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prostaglandin E2 by inhibiting cycloxygenase. Nonethe-
less, this group of medications has gastrointestinal 
complications and even some of them exhibit renal and 
hepatic toxicity (7). Paracetamol, Aminophylline, Tra-
madol, Nefopam etc are some other drugs that have 
been evaluated in different studies for pain relief. Apart 
from these medications, ketamine is another medica-
tion, which has been introduced. It is one of the medica-
tions, which is used for general anesthesia and sedation. 
Ketamine is an antagonist of N-methyl-D-aspartate 
(NMDA) (8, 9) and is used in IV, intramuscular, enteric, 
subcutaneous, intra-nasal, rectal and epidural forms. 
However, at higher doses it can have complications 
such as hallucination, dysphoria, nightmares, an in-
crease in intracranial pressure, hypertension, tachycar-
dia, tremors and clonic-tonic seizures (10, 11). Several 
studies have shown that ketamine is effective in pain 
relief; however, in the majority of studies available, ket-
amine has been used in conjunction with other analge-
sics and no study is available in which use of this medi-
cation alone has been comprehensively evaluated for 
F 
 
 This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). 
Copyright © 2014 Shahid Beheshti University of Medical Sciences. All rights reserved. Downloaded from: www.jemerg.com 
 
Majidinejad et al 78 
pain relief. On the other hand, studies available have 
not evaluated the use of this medication in trauma pa-
tients in emergency units. Therefore, the present study 
was designed to evaluate the effect of ketamine alone 
on pain relief in trauma patients referring to an emer-
gency unit of a third-level hospital. 
Methods: 
Study design and setting 
The present double-blind clinical trial was carried out 
in 2012-2013 in Al-Zahra and Ayatollah Kashani Educa-
tional Centers in Isfahan, Iran. The subjects consisted of 
patients with fractures of long bones, referring to the 
emergency unit. The patients were included in the 
study consecutively. The protocol of the study was ap-
proved by the Ethics Committee of Isfahan University of 
Medical Sciences. The Helsinki Research Protocol was 
observed during the whole study period. The study was 
registered in Iranian registry of clinical trial (IRCT 
number: IRCT2015042812072N3). 
Subject 
The inclusion criteria consisted of an age range of 18-55 
years, fractures of long bones and consent to participate 
in the study. Exclusion criteria consisted of drug abuse, 
trauma to the head, symptoms and signs of increased 
intracranial pressure, a decrease in consciousness level, 
respiratory problems, a history of asthma, contraindica-
tions for ketamine (i.e. a history of cardiac problems, 
especially congestive heart failure, ischemic cardiac 
conditions, hypertension and patients with cerebrovas-
cular attack) and morphine (i.e. asthma, respiratory 
problems, hemodynamic instability). In addition, in case 
of any allergic reaction to any of the medications used, 
the patient was excluded from the study. The sample 
size was estimated at 63 subjects in each group based 
on numeric rating scale (NRS) at 95% confidence inter-
val, a study power of 80%, a standard deviation of 1.6 
for pain severity and a minimum difference significance 
of 2 between the two groups (12).  
Intervention 
First the patients’ demographic and clinical data were 
recorded, which consisted of background diseases, 
drugs taken, drug abuse, drug allergies, the last meal 
eaten, location of fracture and severity of pain. Then the 
eligible patients were randomly divided into two 
groups: the group receiving IV morphine at a dose of 0.1 
mg/kg and the group receiving IV ketamine at a dose of 
0.5 mg/kg. To make sure of the double-blind protocol of 
the study, preparation of the solutions, injections and 
registration of the results were carried out by three 
different physicians who had no contact or relationship 
with each other. The data on the injection of medica-
tions were available only to the chief researcher and the 
medical care personnel were granted access to such 
data only when drug complications arose. In such a 
case, the patient in question was excluded from the 
study. The severity of pain was registered before injec-
tion and 10 minutes after injection based on NRS (13). 
In cases in which pain did not subside after 10 minutes 
(a decrease in pain severity equal to or less than 3), the 
patient received half the initial dose again. Finally, drug 
side effects in patients were evaluated and recorded. 
Statistical analysis 
Data were entered into SPSS 11.5 and were analyzed 
after being transferred to STATA 11.0 software. The 
severity of pain before administration of medications 
and 10 minutes after initiation of treatment, was re-
ported as means ± standard deviations and analyzed 
using independent t-test. Then Kaplan-Meier curves 
and log rank analysis were used to evaluate the success 
of treatment, which was defined as a decrease of 3 
scores in pain severity. Statistical significance was set at 
P<0.05 in all the analyses. 
Results: 
126 patients were included in the study and randomly 
divided into two equal groups of morphine and keta-
mine. The mean ages of the patients in the morphine 
and ketamine groups were 53.6±14.3 and 35.1±13.5 
years, respectively (P=0.54). Forty-five (71.4%) and 51 
(80.95%) patients were male in the ketamine and mor-
phine groups, respectively (P=0.21). Table1 shows the 
site of fractures. The mean pain severity scores at ad-
mission in the ketamine and morphine groups were 
8.8±0.8 and 8.95±0.8, respectively (P=0.32). After ther-
apeutic intervention, the severity of pain decreed signif-
icantly in the ketamine (2.7±1.8; P<0.001) and mor-
phine groups (2.4±1.5; P<0.001), with no significant 
differences between the two groups (P=0.28), indicat-
ing that both medications are equally effective in allevi-
ating pain (Figure 1). Kaplan-Meier curve showed that 
five minutes after initiation of injection, ketamine and 
morphine resulted in a successful decrease in pain se-
verity in 33 (52.4%) and 38 (60.3%) patients, respec-
tively. This rate increased to 59 (93.65%) and 61 
(96.8%) patients, respectively, after 10 minutes. Log 
rank test did not show any significant difference in suc-
cess rates between the two groups (P=0.62) (Figure 2). 
None of the patients receiving morphine exhibited any 
complications; however, during the intervention, six 
patients (9.5%) receiving ketamine developed emer-
Table1: Demographic variables (%) of patients  
Variable Ketamine  Morphine  p 
Gender    
Male 45 (71.4) 51 (81.0) 0.2 
Female 18 (28.6) 12 (19.0)  
Site of fracture    
Upper extremities 23(37.1) 30 (48.4) 0.2 
Lower extremities 39 (62.9) 32 (51.6)  
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gence phenomenon (P=0.28). and four patients (6.3%) 
in this group required a rescue dose due to the short 
period of the drug effect (P=0.12). 
Discussion: 
The results of the present study showed that admin-
istration of a low dose of ketamine (0.5 mg/kg) results 
in a significant decrease in pain severity of long bone 
fractures. This analgesic effect is very similar to that of 
morphine. The incidence of drug complications was 
higher in the ketamine group compared to the mor-
phine group (P=0.028), with emergence phenomenon 
in four subjects. Although the incidence of this compli-
cation was higher in the ketamine group, other studies 
have emphasized that since ketamine is one of the saf-
est and most appropriate medications for sedation in 
emergency wards, such a complication should not pre-
clude its use because this complication is resolved 
spontaneously without any therapeutic intervention 
(14).  
The majority of studies available have evaluated the 
efficacy of combination treatment with morphine/ ket-
amine in decreasing pain due to fractures. Galinski et al 
showed that use of low doses of ketamine decreases the 
need for morphine up to 26% and its efficacy when ad-
ministered alone is similar to that of morphine in alle-
viating pain (5). Weinbroum et al evaluated the simul-
taneous administration of morphine/ketamine com-
pared with morphine alone in decreasing pain severity 
after surgery and showed that simultaneous admin-
istration of morphine and ketamine results in a signifi-
cant decrease in pain severity perception by patients 
(15). A systematic review, too, showed that use of ket-
amine as a supplementary medication results in a de-
crease in the need for morphine, preventing unfavora-
ble complications (16).  
McCarty et al, too, reported that ketamine is an appro-
priate, rapid and safe sedative agent, which facilitates 
reduction of fractures in children in the emergency unit. 
However, they claim that ketamine should only be ad-
ministered in locations, such as emergency units, where 
precise monitoring of patients is possible and an expe-
rienced physician is available in the center for the man-
agement of airways (17). Snijdelaar et al reported that 
the combination of ketamine/morphine significantly 
decreases the need for morphine and has better analge-
sic effects (18). Jennings et al reported similar findings 
but emphasized that more minor complications are 
seen with a combination of morphine/ketamine (12).  
One of the most important limitations of the present 
study was a short follow-up period of patients. In the 
present study, all the patients were evaluated for only 
10 minutes, which precluded evaluation of the effect of 
ketamine at longer periods. Therefore, it is suggested 
that in future studies the efficacy of the medication be 
evaluated at longer follow-up periods. Another short-
coming of the present study was the absence of a place-
bo group. Due to ethical considerations, it was not pos-
sible to follow the patients without any medicinal inter-
vention and use only placebo. It was shown in the pre-
sent study that IV administration of ketamine results in 
pain relief in bone fracture patients. However, the effect 
of this medication on the recurrence of pain is still un-
known. Therefore, it is possible that further administra-
tion of the medication will prevent recurrence of pain. 
In addition, the efficacy of other routes for administra-
tion of the medication, such as intramuscular, intra-
nasal and local use, should be evaluated in future stud-
ies. In addition, use of different administration regi-
mens, such the continuous use or infusion, should be 
evaluated in future studies.  
Conclusion: 
The results of the present study showed that admin-
 
Figure 1: Means (SD) of pain severity in patients receiv-
ing ketamine and morphine before and after interven-
tion. * indicates significant difference from the period 
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Figure 2: The treatment success rate in the morphine 
and ketamine groups at different time intervals.  
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istration of a low dose of ketamine (0.5 mg/kg) results 
in a significant decrease in the severity of acute pain in 
patients with fractures of long bones. This analgesic 
effect is very similar to that of morphine. 
Acknowledgments: 
The authors appreciate the insightful cooperation of 
Medical Sciences and the staffs of the Emergency De-
partment of Al-Zahra Hospital, Isfahan, Iran.  





All authors passed four criteria for authorship contribu-
tion based on recommendations of the International 
Committee of Medical Journal Editors. 
References:  
1. Cameron M. World Report on Road Traffic Injury 
Prevention. Inj Prev. 2004;10(4):255-6. 
2. Griffin XL, Smith N, Parsons N, Costa ML. Ultrasound and 
shockwave therapy for acute fractures in adults. Cochrane 
Database Syst Rev. 2012;2:CD008579. PubMed PMID: 
22336847. 
3. Woolf AD, Erwin J, March L. The need to address the burden 
of musculoskeletal conditions. Best Pract Res Clin Rheumatol. 
2012;26(2):183-224.  
4. Esmailian M, Keshavarz M. Synergistic Effects of Citalopram 
and Morphine in the Renal Colic Pain Relief; a Randomized 
Clinical Trial. Emergency. 2014;1(2):26-9. 
5. Galinski M, Dolveck F, Combes X, et al. Management of 
severe acute pain in emergency settings: ketamine reduces 
morphine consumption. Am J Emerg Med. 2007;25(4):385-90. 
6. Campbell W. Guide to prescribing in today's management of 
severe pain. Prescriber. 2012;23(17):25-40. 
7. Tadros NN, Bland L, Legg E, Olyaei A, Conlin MJ. A single 
dose of a non‐steroidal anti‐inflammatory drug (NSAID) 
prevents severe pain after ureteric stent removal: a 
prospective, randomised, double‐blind, placebo‐controlled 
trial. BJU Int. 2013;111(1):101-5. 
8. Panzer O, Moitra V, Sladen RN. Pharmacology of sedative-
analgesic agents: dexmedetomidine, remifentanil, ketamine, 
volatile anesthetics, and the role of peripheral mu antagonists. 
Anesthesiology clinics. 2011;29(4):587-605. 
9. Roth BL, Gibbons S, Arunotayanun W, et al. The ketamine 
analogue methoxetamine and 3-and 4-methoxy analogues of 
phencyclidine are high affinity and selective ligands for the 
glutamate NMDA receptor. PLoS One. 2013;8(3):e59334. 
10. Klepstad P, Maurset A, Moberg ER, Øye I. Evidence of a 
role for NMDA receptors in pain perception. Eur J Pharmacol. 
1990;187(3):513-8. 
11. Sadove MS, Shulman M, Hatano S, Fevold N. Analgesic 
effects of ketamine administered in subdissociative doses. 
Anesth Analg. 1971;50(3):452-7. 
12. Jennings PA, Cameron P, Bernard S, et al. Morphine and 
Ketamine Is Superior to Morphine Alone for Out-of-Hospital 
Trauma Analgesia: A Randomized Controlled Trial. Ann 
Emerg Med. 2012;59(6):497-503. 
13. Holdgate A, Asha S, Craig J, Thompson J. Comparison of a 
verbal numeric rating scale with the visual analogue scale for 
the measurement of acute pain. Emerg Med. 2003;15(5‐6): 
441-6. 
14. Treston G, Bell A, Cardwell R, Fincher G, Chand D, Cashion 
G. What is the nature of the emergence phenomenon when 
using intravenous or intramuscular ketamine for paediatric 
procedural sedation? Emerg Med Australas. 2009;21(4):315-
22. 
15. Weinbroum AA. A single small dose of postoperative 
ketamine provides rapid and sustained improvement in 
morphine analgesia in the presence of morphine-resistant 
pain. Anesth Analg. 2003;96(3):789-95. 
16. Subramaniam K, Subramaniam B, Steinbrook RA. 
Ketamine as adjuvant analgesic to opioids: a quantitative and 
qualitative systematic review. Anesth Analg. 2004;99(2):482-
95. 
17. McCarty EC, Mencio GA, Walker LA, Green NE. Ketamine 
Sedation for the Reduction of Children's Fractures in the 
Emergency Department. J Bone Joint Surg. 2000;82(7):912. 
18. Snijdelaar DG, Cornelisse HB, Schmid RL, Katz J. A 
randomised, controlled study of peri-operative low dose s(+)-
ketamine in combination with postoperative patient-
controlled s(+)-ketamine and morphine after radical 
prostatectomy. Anaesthesia. 2004;59(3):222-8. 
 
 
 
